Related Experiment Video
Updated: Feb 8, 2026
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
NOS3 Polymorphisms and Chronic Kidney Disease
Alejandro Marín Medina1, Eduardo Esteban Zubero2, Moisés Alejandro Alatorre Jiménez3,4,5
1Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Departamento de Genética, Guadalajara, México.
Insights
Genetic variations in the nitric oxide synthase 3 (NOS3) gene, specifically the Glu298Asp and -786T>C polymorphisms, are linked to faster kidney function decline in chronic kidney disease (CKD) patients.
Area of Science:
- Nephrology
- Genetics
- Cardiovascular Biology
Background:
- Chronic kidney disease (CKD) is an irreversible condition often requiring renal replacement therapy.
- Endothelial dysfunction, a key factor in CKD pathophysiology, involves impaired nitric oxide (NO) synthesis.
- Nitric oxide synthase (NOS) enzymes regulate NO production, with polymorphisms in the NOS3 gene potentially affecting endothelial function.
Purpose of the Study:
- To investigate the association between specific NOS3 gene polymorphisms and the progression of kidney function in patients with CKD.
- To evaluate the impact of Glu298Asp and -786T>C polymorphisms on CKD etiology and disease deterioration.
Main Methods:
- Analysis of NOS3 gene polymorphisms, including Glu298Asp (4b/a) and -786T>C.
- Evaluation of these polymorphisms in CKD patients with both determined and undetermined causes.
- Correlation of genetic findings with the rate of kidney function decline.
Main Results:
- The Glu298Asp and -786T>C polymorphisms in the NOS3 gene were associated with a more rapid deterioration of kidney function in CKD patients.
- This association was observed irrespective of the CKD etiology.
Conclusions:
- Specific NOS3 gene polymorphisms are significant genetic markers for predicting accelerated kidney function loss in chronic kidney disease.
- Targeting endothelial dysfunction mechanisms related to NO synthesis may offer therapeutic avenues for slowing CKD progression.
Abstract:
Chronic kidney disease (CKD) is a multifactorial pathophysiologic irreversible process that often leads to a terminal state in which the patient requires renal replacement therapy. Most cases of CKD are due to chronic-degenerative diseases and endothelial dysfunction is one of the factors that contribute to its pathophysiology. One of the most important mechanisms for proper functioning of the endothelium is the regulation of the synthesis of nitric oxide. This compound is synthesized by the enzyme nitric oxide synthase, which has 3 isoforms. Polymorphisms in the NOS3 gene have been implicated as factors that alter the homeostasis of this mechanism. The Glu298Asp polymorphisms 4 b/a and -786T>C of the NOS3 gene have been associated with a more rapid deterioration of kidney function in patients with CKD. These polymorphisms have been evaluated in patients with CKD of determined and undetermined etiology and related to a more rapid deterioration of kidney function.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
10:51A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
01:24Chronic Kidney Disease II: Clinical Manifestations
01:28Chronic Kidney Disease III: Interprofessional Care
01:18Chronic Kidney Disease IV: Nursing Management
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation